BIOMARIN PHARMACEUTICAL INC (BMRN) Current Reports & Earnings Releases
Upcoming
- 2026-10-26 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-18 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-04 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2026-05-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-27 | 8-K | Material Agreement, Acquisition or Disposition, Direct Financial Obligation, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-04-23 | 8-K | Other Events | SEC |
| 2026-03-16 | 8-K | Other Events | SEC |
| 2026-02-23 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-12 | 8-K | Material Agreement, Direct Financial Obligation, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-29 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-26 | 8-K | Results of Operations, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-01-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-12-22 | 8-K | Other Events | SEC |
| 2025-12-19 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-12-17 | 8-K | Officer / Director Changes | SEC |
| 2025-10-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-07 | 8-K | Results of Operations | SEC |
| 2025-08-11 | 8-K | Officer / Director Changes | SEC |
| 2025-08-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-08-01 | 8-K | Officer / Director Changes | SEC |
| 2025-05-22 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2025-05-16 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-05-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-03 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-02-24 | 8-K | Officer / Director Changes | SEC |
| 2025-02-19 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-29 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-09-24 | 8-K | Reg FD Disclosure | SEC |
| 2024-09-04 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2024-08-28 | 8-K | Item 2.05 | SEC |
| 2024-08-22 | 8-K | Officer / Director Changes | SEC |
| 2024-08-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-05-24 | 8-K | Shareholder Vote Results | SEC |
| 2024-05-14 | 8-K | Item 2.05 | SEC |
| 2024-04-24 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-23 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-22 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-01-11 | 8-K | Officer / Director Changes | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.